Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 6676 AL 6690

Recent Advances on the Role of Brain-Derived Neurotrophic Factor (BDNF) in Neurodegenerative Diseases

Azman KF, Zakaria R.

Int J Mol Sci. 2022 Jun 19;23(12):6827. doi: 10.3390/ijms23126827.

Glutaminyl cyclases, the potential targets of cancer and neurodegenerative diseases

Zhang Y, Wang Y, Zhao Z, Peng W, Wang P, Xu X, Zhao C.

Eur J Pharmacol. 2022 Sep 15;931:175178. doi: 10.1016/j.ejphar.2022.175178. Epub 2022 Aug 7.

Applications of CRISPR-Cas9 in Alzheimer's Disease and Related Disorders

De Plano LM, Calabrese G, Conoci S, Guglielmino SPP, Oddo S, Caccamo A.

Int J Mol Sci. 2022 Aug 5;23(15):8714. doi: 10.3390/ijms23158714.

Insights into the Explicit Protective Activity of Herbals in Management of Neurodegenerative and Cerebrovascular Disorders

Behl T, Makkar R, Sehgal A, Sharma N, Singh S, Albratty M, Najmi A, Meraya AM, Bungau SG.

Molecules. 2022 Aug 4;27(15):4970. doi: 10.3390/molecules27154970.

Alzheimer's Disease as a Major Public Health Concern: Role of Dietary Saponins in Mitigating Neurodegenerative Disorders and Their Underlying Mechanisms

Abduljawad AA, Elawad MA, Elkhalifa MEM, Ahmed A, Hamdoon AAE, Salim LHM, Ashraf M, Ayaz M, Hassan SSU, Bungau S.

Molecules. 2022 Oct 11;27(20):6804. doi: 10.3390/molecules27206804.

The Neuroprotective Potentiality of Flavonoids on Alzheimer's Disease

Calderaro A, Patanè GT, Tellone E, Barreca D, Ficarra S, Misiti F, Laganà G.

Int J Mol Sci. 2022 Nov 27;23(23):14835. doi: 10.3390/ijms232314835.

Acylhydrazones and Their Biological Activity: A Review

Socea LI, Barbuceanu SF, Pahontu EM, Dumitru AC, Nitulescu GM, Sfetea RC, Apostol TV.

Molecules. 2022 Dec 9;27(24):8719. doi: 10.3390/molecules27248719.

Targeting the Nrf2 signaling pathway using phytochemical ingredients: A novel therapeutic road map to combat neurodegenerative diseases

Bai X, Bian Z, Zhang M.

Phytomedicine. 2023 Jan;109:154582. doi: 10.1016/j.phymed.2022.154582. Epub 2022 Nov 30.

A clinicopathological study of selected cognitive impairment cases in Lothian, Scotland: enhanced CJD surveillance in the 65 + population group

Kanguru L, Logan G, Waddel B, Smith C, Molesworth A, Knight R.

BMC Geriatr. 2022 Jul 20;22(1):603. doi: 10.1186/s12877-022-03280-4.

Rivastigmine improves dual-task gait velocity in patients with Alzheimer's disease

Shimura H, Saiko A, Hayashi A, Hattori N, Urabe T.

BMC Neurol. 2021 Feb 10;21(1):61. doi: 10.1186/s12883-021-02098-8.

Melatonin Receptor as a Drug Target for Neuroprotection

Wongprayoon P, Govitrapong P.

Curr Mol Pharmacol. 2021;14(2):150-164. doi: 10.2174/1874467213666200421160835.

Current Updates in Transdermal Therapeutic Systems and Their Role in Neurological Disorders

Yadav N, Mittal A, Ali J, Sahoo J.

Curr Protein Pept Sci. 2021;22(6):458-469. doi: 10.2174/1389203721999201111195512.

Advances in Stem Cell Therapy for Brain Diseases via the Intranasal Route

Dali P, Shende P.

Curr Pharm Biotechnol. 2021;22(11):1466-1481. doi: 10.2174/1389201021666201218130947.

Parkinson´s and Alzheimer´s Diseases and Natural Products: Pathologies and Medication of the New Times

Nabavi SM, Sobarzo-Sánchez E.

Curr Neuropharmacol. 2021;19(2):112-113. doi: 10.2174/1570159X1902201231153120.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias